BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304]
URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6304.htm
Number Citing Articles
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Cells 2021; 10(5): 1097 doi: 10.3390/cells10051097
Kehuan Yin, Xuedong Li, Xiaomin Luo, Yuru Sha, Puyang Gong, Jian Gu, Rui Tan, Rômulo Dias Novaes. Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in RatsEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5345821
Asma Ahrari, Hossein Najafzadehvarzi, Ali Taravati, Fatemeh Tohidi. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expressionLife Sciences 2021; 284: 119884 doi: 10.1016/j.lfs.2021.119884
Yan Xue, Meng Zhang, Tao Li, Feng Liu, Li-Xin Zhang, Xiao-Ping Fan, Bao-Hua Yang, Lei Wang. Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen lossWorld Journal of Gastroenterology 2021; 27(14): 1497-1506 doi: 10.3748/wjg.v27.i14.1497
Paula Sánchez Sánchez, María del Mar Rigual, Nabil Djouder. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis DevelopmentCancers 2021; 13(20): 5045 doi: 10.3390/cancers13205045
Xia Niu, Xiaomei Wang, Bingyu Niu, Yanan Meng, Hongwei He, Yucheng Wang, Guiling Li. Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic EffectPharmaceuticals 2021; 14(10): 951 doi: 10.3390/ph14100951
Xia Niu, Xiaomei Wang, Bingyu Niu, Guoqing Li, Xinyi Yang, Yucheng Wang, Guiling Li. Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In VitroMolecules 2021; 26(6): 1545 doi: 10.3390/molecules26061545
Qiaoting Hu, Mingyu Liu, Yundan You, Guo Zhou, Ye Chen, Hui Yuan, Lulu Xie, Shisong Han, Kangshun Zhu. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosisFree Radical Biology and Medicine 2021; 175: 193 doi: 10.1016/j.freeradbiomed.2021.08.241